About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Upstaza gets nod from Europe for AADC deficiency treatment

LabShares Newton doubles space for biotech startups and launches pitch contest

ICL and PlantArcBio look to use RNAi to boost crop yields

WuXi Biologics to build new center in Singapore as part of $1.4B investment

Alpenglow Biosciences and CorePlus partner to bring 3D spatial biology to clinical R&D

eureKARE launches synthetic biology studio network

ADVERTISEMENT

Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

SINOVAC starts influenza vaccine trial in Chile

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

FORTY51 Ventures closes $43M biotech fund and announces first investment

Ginkgo Bioworks to collaborate with Sumitomo Chemical on animal-free personal care ingredient

Oxford Science Enterprises raises £250M

ADVERTISEMENT